Showing results (551-560 of 1,697) with videos related to
Sort By:
Pageof 170
BMC Cancer|March 13, 2017
A survey to determine usual care after cancer treatment within the United Kingdom national health serviceM Duncan, J Deane, P D White, et al.Journal of the National Cancer Institute|January 8, 2004
BRCA1 and BRCA2 founder mutations and the risk of colorectal cancerBethany L Niell, Gad Rennert, Joseph D Bonner, et al.Psychological Medicine|November 26, 2011
Violent behaviour in U.K. military personnel returning home after deploymentD Macmanus, K Dean, M Al Bakir, et al.Biological Psychiatry|March 1, 1997
Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndromeT J Allain, J A Bearn, P Coskeran, et al.BMJ Military Health|April 29, 2021
Mental well-being interventions in the military: The ten key principlesErin G Lawrence, N Jones, N Greenberg, et al.European Journal of Gynaecological Oncology|November 17, 2010
Liver resection for metastases arising from recurrent granulosa cell tumour of the ovary--a case seriesT K Madhuri, S Butler-Manuel, N Karanjia, et al.Health Economics|February 24, 2021
The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insuranceJiebing Wen, Hefei Wen, J S Butler, et al.Biochimie|November 7, 2015
Positional proteomics in the era of the human proteome project on the doorstep of precision medicineUlrich Eckhard, Giada Marino, Georgina S Butler, et al.The Journal of Biological Chemistry|April 10, 1999
Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanionsG S Butler, S S Apte, F Willenbrock, et al.European Journal of Biochemistry|March 1, 1997
Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinasesG S Butler, H Will, S J Atkinson, et al.Pageof 170